topic is about medical technology of different types, describing specific products under development, the market for them or their impact on healthcare
Cancer is a significant opportunity for the development of tissue engineering and cell therapies, but it is more than just an opportunity currently, since many companies are active and the market for cancer cell/tissue therapies already stands at nearly $500 million.
Currently, OSI Pharmaceuticals has a commanding lead in this area, with its Tarceva being [...]
The applications of surgical sealants, glues and wound closure are many and are rapidly multiplying as more credible data is generated on each application and as physicians gain comfort in working with the products in routine clinical practice.
Below is a sample of surgical sealants, glues and wound closure applications by clinical area:
Source: MedMarket Diligence, LLC; [...]
There are countless disorders, diseases, trauma and other conditions of the human body that can be addressed, in principle, by cellular and tissue-based solutions. These may be due to damage to cells and tissues, such as in burn wounds, skin ulcers, bone fractures and defects and similar conditions in which cell/tissue structure (e.g., skin, [...]
The biggest hurdle remaining to the creation of viable, commercialized embryonic or adult stem cells is to develop the ability to differentiate cells into various types of cells and to determine how these differentiated cells behave when cultivated in large numbers in the laboratory. In many cases, researchers are still uncertain whether the cells retain [...]
There was truly a stunning amount of VC investment in medical technology at the beginning of 2010, with the total funding of medtech in January at over $500 million. (See link.)
Of course January's amount was way above average, but February's was indeed below average, creating a pretty big gap between the January investment of $514 million [...]
(This is drawn in part from the Executive Summary of MedMarket Diligence's "Worldwide Wound Management Market, 2008-2017", Report #S247.)
The skin is our protection from the environment. Far from being just a physical barrier, the skin is a complex organ, protecting our bodies from chemical, biological and physical insult, keeping organs and tissues in their place, [...]
With the initial markets for cell therapy and tissue engineering being best represented by clinical applications in orthopedics and skin/integumentary, a sampling of technologies at various states of development within each is worth considering for insights into likely near-term market impact.
Below are select technologies under development by companies in cell therapy and tissue engineering. While [...]
A large (nearly $7 billion) and diverse current opportunity exists for applications of cell therapy and tissue engineering. This diverse “market” (which is actually comprised of many different clinical and technology market segments) has grown from unassuming roots over only a few years and is now on track to eclipse even the wild expectations of [...]
Cell Therapy is defined as a process whereby new cells are introduced into tissue as a method of treating disease; the process may or may not include gene therapy. Forms of cell therapy can include: transplantation of autologous (from the patient) or allogeneic (from a donor) stem cells , transplantation of mature, functional cells, application [...]
The global market for coronary stents is estimated to be in excess of $7 billion and projected to be growing at 6% per year. With the average age of citizens in developed countries increasing, there is an increased need to provide medical care to the average citizen. As such, an aging population translates into increasing [...]
Contact:
